arXiv:2609.00189v1 Announce Type: new
Abstract: Goal-directed optimization is essential for steering molecular generators to propose candidates with desired properties. However, it is often implement...
By Shiyun Wa, Yifei Wang, Anna G. Green, Simone Sciabola, Ye Wang
arXiv:2606. 18961v1 Announce Type: new Abstract: Protein language models (PLMs) have emerged as powerful tools for controllable biomolecular design, yet their post-training adaptation typically relies on costly wet-lab validation or curated preference datasets.
By Lanqing Li, Shentong Mo, Yang Yu, Pheng-Ann Heng
arXiv:2607. 19044v1 Announce Type: new Abstract: Leveraging large language models (LLMs) for molecular generation has shown remarkable potential in chemical and drug design.
By Mingxuan Ouyang, Hao Lan, Wanyu Lin
The paper explores how large language models (LLMs) can be trained for small-molecule drug design by using synthetic tasks that are cheaper to evaluate. By employing a curriculum that gradually increases task difficulty, the authors demonstrate that LLMs can learn design strategies that outperform larger models on structure-based lead optimization. This approach shows that scaling post‑training with synthetic tasks can effectively adapt LLMs to high‑cost experimental scenarios that are otherwise infeasible to train on directly.
By Frank Hu, Shriram Chennakesavalu, Zichen Wang, Patricia Suriana, Bodhi Vani, Kirill Shmilovich, Kangway Chuang, Colin Grambow
Protein language models (PLMs) have emerged as powerful tools for controllable biomolecular design, yet their post-training adaptation typically relies on costly wet-lab validation or curated preference datasets. To overcome this supervision bottleneck, we introduce unsupervised reward optimization of PLMs, a comprehensive framework for steerable protein generation without ground-truth labels.
arXiv:2606. 01220v1 Announce Type: cross Abstract: Generating molecules that simultaneously satisfy drug-like properties and conform to the 3D structure of a target protein is a core challenge in structure-based drug design (SBDD).
By Guang Lin, Shikui Tu, Lei Xu